Promising Preclinical Results on AIDS Vaccine
Nationwide Children's HospitalResearchers at Columbus Children's Hospital and its collaborators, Targeted Genetics Corporation and the International AIDS Vaccine Initiative, have demonstrated that utilizing a recombinant adeno-associated virus (rAAV)-based HIV vaccine resulted in robust and sustained antibody and T cell immune responses in non-human primates (monkeys).